8AK:FRA
Alkermes Plc
€42.30
arrow_downward
-2.22%(-0.96) 1D
Aug 3, 8:07:45 AM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 8AK...
Open
€42.30
High
€42.30
Low
€42.30
Mkt. cap
8.22B
Avg. vol.
12.00
Volume
0.00
52-wk high
€48.19
52-wk low
€22.00
No. of employees
2K
Open
€42.30
High
€42.30
Low
€42.30
Mkt. cap
8.22B
Avg. vol.
12.00
Volume
0.00
52-wk high
€48.19
52-wk low
€22.00
No. of employees
2K
News stories
From sources across the web
https://www.dars.gov.et/
·
1 month ago
ALKS Q1 2026 Earnings: EPS Surprises to the Upside, Stock Gains 4.95% - Earnings Cycle Report
Profile
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio. Wikipedia
About Alkermes Plc
CEORichard F. Pops | Richard F. Pops
Employees2.05K
Founded1987
Headquarters-
SectorBiotechnology
Websitealkermes.com
AI content may include mistakes. Learn more